Elevai Labs Inc. (NASDAQ: ELAB)’s stock price has plunge by 7.01relation to previous closing price of 0.09. Nevertheless, the company has seen a -0.64% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2024-10-04 that NEWPORT BEACH, Calif., Oct. 04, 2024 (GLOBE NEWSWIRE) — Elevai Labs, Inc. (NASDAQ: ELAB) (“Elevai” or the “Company”), a leader in medical aesthetics, today announced the commencement of an offer to exchange up to 15,000,000 shares of its currently issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”) for up to 15,000,000 shares of the Company’s newly issued Series B Preferred Stock (“Series B Preferred Stock”), with each share of Common Stock being exchangeable in for one share of Series B Preferred Stock.
Is It Worth Investing in Elevai Labs Inc. (NASDAQ: ELAB) Right Now?
The public float for ELAB is 16.58M, and currently, short sellers hold a 4.14% ratio of that floaft. The average trading volume of ELAB on October 21, 2024 was 14.43M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ELAB’s Market Performance
ELAB’s stock has seen a -0.64% decrease for the week, with a -69.56% drop in the past month and a -80.02% fall in the past quarter. The volatility ratio for the week is 9.62%, and the volatility levels for the past 30 days are at 13.41% for Elevai Labs Inc. The simple moving average for the last 20 days is -3.59% for ELAB stock, with a simple moving average of -84.00% for the last 200 days.
ELAB Trading at -57.29% from the 50-Day Moving Average
After a stumble in the market that brought ELAB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.81% of loss for the given period.
Volatility was left at 13.41%, however, over the last 30 days, the volatility rate increased by 9.62%, as shares sank -66.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -72.70% lower at present.
During the last 5 trading sessions, ELAB fell by -0.64%, which changed the moving average for the period of 200-days by -94.93% in comparison to the 20-day moving average, which settled at $0.0966. In addition, Elevai Labs Inc. saw -94.91% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ELAB
Current profitability levels for the company are sitting at:
- -2.0 for the present operating margin
- 0.68 for the gross margin
The net margin for Elevai Labs Inc. stands at -1.92. The total capital return value is set at -1.58.
Based on Elevai Labs Inc. (ELAB), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -42.89. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is -74.14.
Currently, EBITDA for the company is -3.75 million with net debt to EBITDA at -0.01. When we switch over and look at the enterprise to sales, we see a ratio of 1.87. The receivables turnover for the company is 85.08for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.05.
Conclusion
In a nutshell, Elevai Labs Inc. (ELAB) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
